Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a


criptococică şi imunosupresie



Yüklə 4,39 Mb.
səhifə47/50
tarix25.07.2018
ölçüsü4,39 Mb.
#58042
1   ...   42   43   44   45   46   47   48   49   50

criptococică şi imunosupresie.

Profilaxia secundară a candidozei orofaringiene la

pacienţi cu imunosupresie.

Tratamentul meningitei criptococice la pacienţii care

nu pot lua sau nu tolerează amfotericina.

Tratamentul candidozelor severe şi care pun în pericol

viaţa la pacienţi care nu tolerează amfotericina.

Tratamentul candidozei orofaringiene la pacienţi cu

imunosupresie.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J02AC01 FLUCONAZOLUM CAPS. 100 mg

DIFLAZON 100 mg 100 mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100 mg TERAPIA S.A.

FLUCOVIM 100 100 mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100 mg BALKANPHARMA RAZGRAD AD
J02AC01 FLUCONAZOLUM CAPS. 150 mg

DIFLAZON 150 mg 150 mg KRKA D.D.

DIFLUCAN 150 mg 150 mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150 mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150 mg MEDICO UNO PHARMACEUTICAL

SRL


FLUCONAZOL MEDOCHEMIE 150 mg 150 mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ(R) 150 150 mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150 mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150 mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150 mg TERAPIA S.A.

FLUCOVIM 150 150 mg VIM SPECTRUM SRL

MYCOMAX 150 150 mg ZENTIVA AS

MYCOSYSTA(R) 150 mg 150 mg GEDEON RICHTER PLC.


J02AC01 FLUCONAZOLUM CAPS. 200 mg

DIFLAZON 200 mg 200 mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200 mg TEVA PHARMACEUTICALS SRL
J02AC01 FLUCONAZOLUM SOL. PERF. 2 mg/ml

DIFLAZON(R) 2 mg/ml KRKA D.D.

DIFLUCAN(R) 2 mg/ml PFIZER EUROPE MA EEIG

MYCOMAX(R)INF 2 mg/ml ZENTIVA AS


J02AC01 FLUCONAZOLUM CAPS. 50 mg

DIFLAZON 50 mg 50 mg KRKA D.D.

DIFLUCAN 50 mg 50 mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50 mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50 mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ(R) 50 50 mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50 mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50 mg TERAPIA S.A.

FLUCOVIM 50 50 mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50 mg BALKANPHARMA RAZGRAD AD
J02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALA 50 mg/5 ml

DIFLUCAN(R) 50 mg/5 ml 50 mg/5 ml PFIZER EUROPE MA EEIG

________________________________________________________________________________
______________________________________________________________________________

| 1006 |J02AC03| VORICONAZOLUM** | Protocol: J012B |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J02AC03 VORICONAZOLUM COMPR. FILM. 200 mg

VFEND 200 mg 200 mg PFIZER LTD.
J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF. 200 mg

VFEND 200 mg 200 mg PFIZER LTD.


J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALA 40 mg/ml

VFEND 40 mg/ml 40 mg/ml PFIZER LTD.


J02AC03 VORICONAZOLUM COMPR. FILM. 50 mg

VFEND 50 mg 50 mg PFIZER LTD.

________________________________________________________________________________
______________________________________________________________________________

| 1008 |J05AB01| ACICLOVIRUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J05AB01 ACICLOVIRUM CAPS. 200 mg

ACICLOVIR 200 mg 200 mg ARENA GROUP SA

EUVIROX 200 mg 200 mg EUROPHARM SA


J05AB01 ACICLOVIRUM COMPR. 200 mg

ACICLOVIR 200 mg 200 mg TERAPIA SA

CLOVIRAL 200 mg 200 mg ANTIBIOTICE SA

ZOVIRAX 200 mg GLAXO WELLCOME FOUNDATION

LTD.

J05AB01 ACICLOVIRUM COMPR. DISP. 200 mg



ACICLOVIR 200 mg 200 mg OZONE LABORATORIES LTD.
LOVIR 200 mg 200 mg RANBAXY UK LIMITED
J05AB01 ACICLOVIRUM PULB. PT. SOL. 250 mg

INJ./PERF.

VIROLEX 250 mg KRKA D.D. NOVO MESTO
J05AB01 ACICLOVIRUM CAPS. 400 mg

ACICLOVIR 400 mg 400 mg ARENA GROUP SA


J05AB01 ACICLOVIRUM COMPR. 400 mg

ACICLOVIR 400 mg 400 mg EGIS PHARMACEUTICALS

P.L.C.
J05AB01 ACICLOVIRUM COMPR. FILM. 400 mg

ACIKLOVIR 400 mg A & G MED TRADING S.R.L.

________________________________________________________________________________
______________________________________________________________________________

| 1009 |J05AB14| VALGANCICLOVIRUM** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul de iniţiere şi menţinere pentru retinita cu citomegalovirus (CMV) la pacienţi imunocompromişi.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg

VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL

________________________________________________________________________________


______________________________________________________________________________

| 1010 |L04AA01| CICLOSPORINUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Managementul rejectului de grefă la pacienţii supuşi procedurii de transplant.

Monitorizarea atentă a pacienţilor este obligatorie.



Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA01 CICLOSPORINUM CAPS. MOI 100 mg

EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS

S.R.O.
L04AA01 CICLOSPORINUM SOL. ORALA 100 mg/ml

EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS

S.R.O.


SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 25 mg

CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG

EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS

S.R.O.


SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH
L04AA01 CICLOSPORINUM CAPS. MOI 50 mg

CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG

EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS

S.R.O.


SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________


______________________________________________________________________________

| 1012 |L04AA06| MYCOPHENOLATUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 180 mg

MYFORTIC 180 mg 180 mg NOVARTIS PHARMA GMBH
L04AA06 MYCOPHENOLATUM PULB. PT. SUSP. ORALA 1 g/5 ml

CELLCEPT 1 mg/5 ml 1 g/5 ml ROCHE REGISTRATION LTD.


L04AA06 MYCOPHENOLATUM CAPS. 250 mg

CELLCEPT 250 mg 250 mg ROCHE REGISTRATION LTD.

MYFENAX 250 mg 250 mg TEVA PHARMA BV
L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 360 mg

MYFORTIC 360 mg 360 mg NOVARTIS PHARMA GMBH


L04AA06 MYCOPHENOLATUM CAPS. 500 mg

MYFENAX 500 mg 500 mg TEVA PHARMA BV


L04AA06 MYCOPHENOLATUM COMPR. FILM. 500 mg

CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD.


L04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. 500 mg

SOL. PERF.

CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD.

________________________________________________________________________________


______________________________________________________________________________

| 1013 |L04AA09| BASILIXIMABUM** | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. 20 mg

INJ./PERF.

SIMULECT 20 mg 20 mg NOVARTIS EUROPHARM LTD.

________________________________________________________________________________
______________________________________________________________________________

| 1014 |L04AX01| AZATHIOPRINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg

IMURAN(R) 50 mg THE WELLCOME FOUNDATION

LTD.


________________________________________________________________________________
______________________________________________________________________________

| 1015 |N02AX02| TRAMADOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Durere severă, care nu răspunde la analgezice

non-opioide.

Pentru durere acută la care tratamentul cu aspirină

şi/sau paracetamol este contraindicat sau nu a dat

rezultate.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N02AX02 TRAMADOLUM COMPR. ELIB. MODIF. 100 mg


TRAMADOLOR(R) 100 ID 100 mg HEXAL AG
N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 100 mg

NOAX UNO 100 mg 100 mg LABOPHARM EUROPE LIMITED

TRALGIT SR 100 100 mg ZENTIVA AS

TRAMADOL(R) RETARD 100 mg KRKA D.D.


N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 100 mg

PREL.


TRAMAL RETARD 100 mg 100 mg GRUNENTHAL GMBH
N02AX02 TRAMADOLUM SOL. INJ. 100 mg

MABRON 100 mg MEDOCHEMIE LTD.

TRADOLAN 100 mg LANNACHER HEILMITTEL GMBH
Prescriere limitată: Tratamentul de scurtă durată al durerii acute.
N02AX02 TRAMADOLUM SUPOZ. 100 mg

TRADOLAN 100 mg LANNACHER HEILMITTEL GMBH

TRAMADOL 100 mg KRKA D.D.

TRAMAG 100 100 mg MAGISTRA C & C

TRAMAL(R) 100 mg GRUNENTHAL GMBH
N02AX02 TRAMADOLUM SOL. INJ. 100 mg/2 ml

TRALGIT 100 100 mg/2 ml ZENTIVA A.S.


Prescriere limitată: Tratamentul de scurtă durată al durerii acute.
N02AX02 TRAMADOLUM PIC. ORALE, SOL. 100 mg/ml

TRALGIT 100 mg/ml ZENTIVA A.S.


N02AX02 TRAMADOLUM SOL. ORALA 100 mg/ml

TRADOLAN 100 mg/ml LANNACHER HEILMITTEL GMBH


N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 150 mg

TRALGIT SR 150 150 mg ZENTIVA AS


N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 150 mg

PREL.


TRAMADOL RETARD 150 mg 150 mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 150 mg 150 mg GRUNENTHAL GMBH


N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 200 mg
NOAX UNO 200 mg 200 mg LABOPHARM EUROPE LIMITED

TRALGIT SR 200 200 mg ZENTIVA AS


N02AX02 TRAMADOLUM COMPR. FILM. ELIB. 200 mg

PREL.


TRAMADOL RETARD 200 mg 200 mg KRKA D.D. NOVO MESTO

TRAMAL RETARD 200 mg 200 mg GRUNENTHAL GMBH


N02AX02 TRAMADOLUM COMPR. ELIB. PREL. 300 mg

NOAX UNO 300 mg 300 mg LABOPHARM EUROPE LIMITED


N02AX02 TRAMADOLUM CAPS. 50 mg

K-ALMA(R) 50 mg ANTIBIOTICE SA

MABRON 50 mg 50 mg MEDOCHEMIE LTD.

TRALGIT 50 50 mg ZENTIVA A.S.

TRAMACALM 50 mg AC HELCOR SRL

TRAMADOL 50 mg KRKA D.D.

TRAMADOL LPH 50 mg 50 mg LABORMED PHARMA SA

TRAMADOL AL 50 50 mg ALIUD(R) PHARMA

GMBH & CO. KG

TRAMADOL ARENA 50 mg ARENA GROUP S.A.

TRAMAL(R) 50 mg GRUNENTHAL GMBH

URGENDOL 50 mg MEDICAROM GROUP SRL


N02AX02 TRAMADOLUM COMPR. 50 mg

TRAMADOL 50 mg 50 mg OZONE LABORATORIES LTD.

TRAMADOL EEL 50 mg BIO EEL SRL

TRAMAG 50 50 mg MAGISTRA C & C


N02AX02 TRAMADOLUM COMPR. FILM. 50 mg

TRADOLAN 50 mg 50 mg LANNACHER HEILMITTEL GMBH


N02AX02 TRAMADOLUM SOL. INJ. 50 mg

TRADOLAN 50 mg 50 mg LANNACHER HEILMITTEL GMBH


Prescriere limitată: Tratamentul de scurtă durată al durerii acute
N02AX02 TRAMADOLUM SOL. INJ. 50 mg/ml

TRALGIT 50 50 mg/ml ZENTIVA A.S.

TRAMADOL 50 mg/ml KRKA D.D.

TRAMADOL(R) AL 100 Fiole 50 mg/ml ALIUD(R) PHARMA

GMBH & CO. KG

TRAMAL(R) 100 50 mg/ml GRUNENTHAL GMBH

TRAMAL(R) 50 50 mg/ml GRUNENTHAL GMBH

URGENDOL 50 mg/ml MEDICAROM GROUP SRL


Prescriere limitată: Tratamentul de scurtă durată al durerii acute
N02AX02 TRAMADOLUM PIC. ORALE, SOL.

TRAMADOL AL PICATURI ALIUD PHARMA GMBH & CO. KG


N02AX02 TRAMADOLUM PICATURI ORALE - SOL 100 mg/ml

TRAMAL(R) 100 mg/ml GRUNENTHAL GMBH

________________________________________________________________________________
SUBLISTA C2 - P9: PROGRAM NAŢIONAL DE TRANSPLANT DE ORGANE, ŢESUTURI ŞI CELULE DE ORIGINE UMANĂ. P9.7 TRATAMENTUL STĂRII POSTTRANSPLANT ÎN AMBULATORIU A PACIENŢILOR TRANSPLANTAT!
______________________________________________________________________________

| 1016 |A05AA02| ACIDUM URSODEOXYCHOLICUM | |

|_______|_______|____________________________________________|_________________|
NOTĂ:

Nu se va prescrie în regim compensat pentru tratamentul litiazei biliare.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

A05AA02 ACIDUM CAPS. 250 mg

URSODEOXYCHOLICUM

URSOFALK(R) 250 mg DR. FALK PHARMA GMBH

URSOSAN 250 mg PRO. MED. CS PRAHA AS

________________________________________________________________________________


#M4

______________________________________________________________________________

| 1017 | *** Abrogată |

|_______|______________________________________________________________________|
______________________________________________________________________________

| 1018 | *** Abrogată |

|_______|______________________________________________________________________|
______________________________________________________________________________

| 1019 | *** Abrogată |

|_______|______________________________________________________________________|
#B

______________________________________________________________________________

| 1021 |H02AB04| METHYLPREDNISOLONUM | |

|_______|_______|____________________________________________|_________________|


________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 125 mg

LEMOD SOLU 125 mg 125 mg HEMOFARM S.R.L.
H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 125 mg/2 ml

INJ.


SOLU-MEDROL ACT-O-VIAL 125 mg/2 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM COMPR. 16 mg

MEDROL A 16 16 mg PFIZER EUROPE MA EEIG


H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 20 mg

LEMOD SOLU 20 mg 20 mg HEMOFARM S.R.L.


H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 250 mg/4 ml

INJ.


SOLU-MEDROL ACT-O-VIAL 250 mg/4 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM COMPR. 32 mg

MEDROL 32 32 mg PFIZER EUROPE MA EEIG


H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 40 mg

LEMOD SOLU 40 mg 40 mg HEMOFARM S.R.L.


H02AB04 METHYLPREDNISOLONUM LIOF. SI SOLV. PT. SOL. 40 mg/1 ml

INJ.


SOLU-MEDROL ACT-O-VIAL 40 mg/1 ml PFIZER EUROPE MA EEIG
H02AB04 METHYLPREDNISOLONUM COMPR. 4 mg

MEDROL 4 mg 4 mg PFIZER EUROPE MA EEIG


H02AB04 METHYLPREDNISOLONUM LIOF. PT. SOL. INJ. 500 mg

LEMOD SOLU 500 mg 500 mg HEMOFARM S.R.L.


H02AB04 METHYLPREDNISOLONUM LIOF. + SOLV. PT. SOL. 500 mg/7.8 ml

INJ.


SOLU-MEDROL 500 mg/7,8 ml 500 mg/7.8 ml PFIZER EUROPE MA EEIG

________________________________________________________________________________


______________________________________________________________________________

| 1022 |H02AB07| PREDNISONUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

H02AB07 PREDNISONUM COMPR. 5 mg

N-PREDNISON 5 mg MEDUMAN SA

PREDNISON 5 mg 5 mg SINTOFARM SA

PREDNISON ARENA 5 mg 5 mg ARENA GROUP SA

PREDNISON GEDEON RICHTER 5 mg 5 mg GEDEON RICHTER ROMANIA SA

PREDNISON MAGISTRA 5 mg 5 mg MAGISTRA C & C

________________________________________________________________________________


______________________________________________________________________________

| 1023 |J01EE01| SULFAMETHOXAZOLUM + TRIMETHOPRIMUM | |

|_______|_______|____________________________________________|_________________|
Există un risc crescut de reacţie adversă severă la administrarea acestui medicament la persoane în vârstă.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J01EE01 SULFAMETHOXAZOLUM + SUSP. ORALA 200 mg/40 mg/5 ml

TRIMETHOPRIMUM

EPITRIM 200 mg/40 mg/5 ml E.I.P.I.CO. MED S.R.L.


J01EE01 SULFAMETHOXAZOLUM + SIROP 25 mg/5 mg/ml

TRIMETHOPRIMUM

SUMETROLIM 25 mg/5 mg/ml EGIS PHARMACEUTICALS

P.L.C.
J01EE01 SULFAMETHOXAZOLUM + COMPR. 400 mg/80 mg

TRIMETHOPRIMUM

BISEPTRIM 400 mg/80 mg EUROPHARM SA

CO-TRIMELL 400 mg/80 mg BIO EEL SRL

SUMETROLIM 400 mg/80 mg EGIS PHARMACEUTICALS

P.L.C.

TAGREMIN 400 mg/80 mg ZENTIVA S.A.


J01EE01 SULFAMETHOXAZOLUM + SOL. PERF. 400 mg/80 mg

TRIMETHOPRIMUM

SEPTRIN 400 mg/80 mg THE WELLCOME FOUNDATION

LTD.


________________________________________________________________________________
______________________________________________________________________________

| 1024 |J02AC01| FLUCONAZOLUM | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratament de întreţinere la pacienţi cu meningită

criptococică şi imunosupresie.

Profilaxia secundară a candidozei orofaringiene la

pacienţi cu imunosupresie.

Tratamentul meningitei criptococice la pacienţii care

nu pot lua sau nu tolerează amfotericina.

Tratamentul candidozelor severe şi care pun în pericol

viaţa la pacienţi care nu tolerează amfotericina.

Tratamentul candidozei orofaringiene la pacienţi cu

imunosupresie.

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J02AC01 FLUCONAZOLUM CAPS. 100 mg

DIFLAZON 100 mg 100 mg KRKA D.D.

FLUCONAZOLE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL

FLUCORIC 100 mg 100 mg TERAPIA S.A.

FLUCOVIM 100 100 mg VIM SPECTRUM SRL

FUNGOLON 100 mg 100 mg BALKANPHARMA RAZGRAD AD
J02AC01 FLUCONAZOLUM CAPS. 150 mg

DIFLAZON 150 mg 150 mg KRKA D.D.

DIFLUCAN 150 mg 150 mg PFIZER EUROPE MA EEIG

FLUCONAZOL 150 mg 150 mg OZONE LABORATORIES LTD.

FLUCONAZOL MEDICO UNO 150 mg 150 mg MEDICO UNO PHARMACEUTICAL

SRL


FLUCONAZOL MEDOCHEMIE 150 mg 150 mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ(R) 150 150 mg SANDOZ SRL

FLUCONAZOL TERAPIA 150 mg 150 mg TERAPIA SA

FLUCONAZOLE TEVA 150 mg 150 mg TEVA PHARMACEUTICALS SRL

FLUCORIC 150 mg 150 mg TERAPIA S.A.

FLUCOVIM 150 150 mg VIM SPECTRUM SRL

MYCOMAX 150 150 mg ZENTIVA AS

MYCOSYSTA(R) 150 mg 150 mg GEDEON RICHTER PLC.


J02AC01 FLUCONAZOLUM CAPS. 200 mg

DIFLAZON 200 mg 200 mg KRKA D.D.

FLUCONAZOLE TEVA 200 mg 200 mg TEVA PHARMACEUTICALS SRL
J02AC01 FLUCONAZOLUM SOL. PERF. 2 mg/ml

DIFLAZON(R) 2 mg/ml KRKA D.D.

DIFLUCAN(R) 2 mg/ml PFIZER EUROPE MA EEIG

MYCOMAX(R) INF 2 mg/ml ZENTIVA AS


J02AC01 FLUCONAZOLUM CAPS. 50 mg

DIFLAZON 50 mg 50 mg KRKA D.D.

DIFLUCAN 50 mg 50 mg PFIZER EUROPE MA EEIG

FLUCONAZOL 50 mg 50 mg ARENA GROUP SA

FLUCONAZOL MEDOCHEMIE 50 mg 50 mg MEDOCHEMIE ROMANIA SRL

FLUCONAZOL SANDOZ(R) 50 50 mg SANDOZ SRL

FLUCONAZOL TERAPIA 50 mg 50 mg TERAPIA S.A.

FLUCONAZOLE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL

FLUCORIC 50 mg 50 mg TERAPIA S.A.

FLUCOVIM 50 50 mg VIM SPECTRUM SRL

FUNGOLON 50 mg 50 mg BALKANPHARMA RAZGRAD AD
J02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALA 50 mg/5 ml

DIFLUCAN(R) 50 mg/5 ml 50 mg/5 ml PFIZER EUROPE MA EEIG

________________________________________________________________________________
______________________________________________________________________________

| 1025 |J02AC03| VORICONAZOLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF.

VFEND(R) 200 mg PFIZER LIMITED

VFEND 200 mg 200 mg PFIZER LTD.


J02AC03 VORICONAZOLUM COMPR. FILM. 50 mg

VFEND 50 mg 50 mg PFIZER LTD.


J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALA

VFEND(R) 40 mg/ml 40 mg/ml PFIZER LIMITED

________________________________________________________________________________
______________________________________________________________________________

| 1026 |J02AC04| POSACONAZOLUM** | |

|_______|_______|____________________________________________|_________________|
Prescriere limitată: Profilaxia şi tratamentul infecţiilor fungice invazive


Yüklə 4,39 Mb.

Dostları ilə paylaş:
1   ...   42   43   44   45   46   47   48   49   50




Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©muhaz.org 2024
rəhbərliyinə müraciət

gir | qeydiyyatdan keç
    Ana səhifə


yükləyin